Mannitol

Basic Information


CAS ID: 69-65-8
Molecular Formula: C6H14O6
Molecular Weight: 182.2 g/mol
Monoisotopic Mass: 182.079 g/mol
Class: Small Molecule
Natural Product: Yes
Other Names: Diosmol | BRONCHITOL | MANNA SUGAR | RESECTISOL | E421 | MANNITE | MANNITOL | OSMITROL | ARIDOL KIT | Alexitol sodium | D-MANNITOL
Analysis: Drug repositioning mechanism analysis

OH OH OH OH OH HO


Compound Structure and Identifier


InChI: InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1 See All
InChI Key: FBPFZTCFMRRESA-KVTDHHQDSA-N
Smiles: OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO See All
Molfile: Download


Related Target



Related Fibrosis Property


Trial Record 1

ClinicalTrial ID NCT00117208 Disease Cystic fibrosis
Phase Phase 2 Status Completed
First Received July 4, 2005 Last Verified February 2, 2010
Sponsor Pharmaxis

Trial Record 2

ClinicalTrial ID NCT00446680 Disease Cystic fibrosis
Phase Phase 3 Status Completed
First Received March 13, 2007 Last Verified June 25, 2010
Sponsor Pharmaxis

Trial Record 3

ClinicalTrial ID NCT00792714 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received November 18, 2008 Last Verified February 2, 2010
Sponsor Pharmaxis

Trial Record 4

ClinicalTrial ID NCT00251056 Disease Cystic fibrosis
Phase Phase 2 Status Completed
First Received November 9, 2005 Last Verified August 29, 2008
Sponsor Pharmaxis

Trial Record 5

ClinicalTrial ID NCT02134353 Disease Cystic fibrosis
Phase Phase 3 Status Completed
First Received May 9, 2014 Last Verified March 9, 2018
Sponsor Pharmaxis

Trial Record 6

ClinicalTrial ID NCT00455130 Disease Cystic fibrosis
Phase Phase 2 Status Completed
First Received April 3, 2007 Last Verified February 2, 2010
Sponsor Pharmaxis

Trial Record 7

ClinicalTrial ID NCT01883531 Disease Cystic fibrosis
Phase Phase 2 Status Completed
First Received June 21, 2013 Last Verified October 14, 2015
Sponsor Pharmaxis

Trial Record 8

ClinicalTrial ID NCT01887197 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received June 26, 2013 Last Verified November 6, 2018
Sponsor Tim Corcoran

Trial Record 9

ClinicalTrial ID NCT01309178 Disease Cystic fibrosis
Phase Phase 2 Status Unknown
First Received March 7, 2011 Last Verified March 7, 2011
Sponsor University Children’s Hospital Tuebingen

Trial Record 10

ClinicalTrial ID NCT00630812 Disease Cystic fibrosis
Phase Phase 3 Status Completed
First Received March 7, 2008 Last Verified August 15, 2012
Sponsor Pharmaxis

Related Link


PubChem: 6251
ChEMBL: CHEMBL689